Medplus Subsidiary Receives Drug License Suspension Order
Medplus Health Services Limited announced that Optival Health Solutions Private Limited, a subsidiary, has received a suspension order for a Drug License. The order pertains to a store located on Parkal Main Road in Telangana.According to the company, the Assistant Director, Drugs Control Administration, Warangal, Telangana, issued an order suspending the Drug License for a period of three days. The order was received on March 28, 2026, and is based on a violation of Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945.
The company estimates a potential revenue loss of Rs 0.60 lacs as a result of the suspension.
Further details are available on the company website at www.medplusindia.com, as well as on the websites of the BSE Limited and the National Stock Exchange of India Ltd.
| Name(s) of Authority | Nature and details of the action(s) taken, initiated or order(s) passed | Date of receipt of direction or order | Details of the violation(s)/ contravention(s) committed or alleged to be committed | Impact on financial operation |
|---|---|---|---|---|
| Assistant Director, Drugs Control Administration, Warangal, Telangana. | Suspension of Drug License for three days | Order received on 28.03.2026 | Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 | Potential Revenue Loss of Rs 0.60 lacs. |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.